Home LiteratureArticle Details
PMID: 12297568 Published · ppublish English Journal Article Multicenter Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.

Neurology ·Vol. 59 ·No. 6 ·2002-09-24 ·Pages 867-73

Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC

Abstract

To examine volumetric MRI correlates of longitudinal cognitive decline in normal aging, AD, and subcortical cerebrovascular brain injury (SCVBI). Previous cross-sectional studies examining the relationship between cognitive impairment and dementia have shown that hippocampal and cortical gray matter atrophy are the most important predictors of cognitive impairment, even in cases with SCVBI. The authors hypothesized that hippocampal and cortical gray matter volume also would best predict rate of cognitive decline in cases with and without SCVBI. Subjects were recruited for a multicenter study of contributions to dementia of AD and SCVBI. The sample (n = 120) included cognitively normal, cognitively impaired, and demented cases with and without lacunes identified by MRI. Cases with cortical strokes were excluded. Average length of follow-up was 3.0 years. Measures of hippocampal volume, volume of cortical gray matter, presence of subcortical lacunes, and volume of white matter hyperintensity were derived from MRI. Random effects modeling of longitudinal data was used to assess effects of baseline MRI variables on longitudinal change in a measure of global cognitive ability. Cortical gray matter atrophy predicted cognitive decline regardless of whether lacunes were present. Hippocampal atrophy predicted decline only in those without lacunes. Neither lacunes nor white matter hyperintensity independently predicted decline. Results suggest that cortical atrophy is an index of disease severity in both AD and subcortical cerebrovascular brain injury and consequently predicts faster progression. Hippocampal volume may index disease severity and predict progression in AD. The absence of this effect in cases with lacunes suggests that this group is etiologically heterogeneous and is not composed simply of cases of AD with incidental stroke.

MeSH Terms
Aged Aged, 80 and over Alzheimer Disease/pathology,psychology Cerebral Cortex/pathology Cerebrovascular Disorders/pathology,psychology Cognition Disorders/pathology,psychology Female Follow-Up Studies Forecasting Hippocampus/pathology Humans Longitudinal Studies Magnetic Resonance Imaging/statistics & numerical data Male Middle Aged Neuropsychological Tests/statistics & numerical data Regression Analysis
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Mungas D
Department of Neurology, School of Medicine, University of California, Davis, USA. dmmungas@ucdavis.edu
Reed B R
Jagust W J
DeCarli C
Mack W J
Kramer J H
Weiner M W
Schuff N
Chui H C
References (24)
24 references, click to expand
  1. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
    Neurology. 1999 Apr 22;52(7):1397-403 PMID: 10227624
  2. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.
    J Neurol. 1999 Jun;246(6):477-85 PMID: 10431775
  3. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.
    Neurology. 2000 Dec 12;55(11):1626-35 PMID: 11113215
  4. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease.
    Arch Neurol. 2001 Aug;58(8):1243-7 PMID: 11493164
  5. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.
    Neurology. 2001 Dec 26;57(12):2229-35 PMID: 11756602
  6. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.
    Neurology. 1992 Mar;42(3 Pt 1):473-80 PMID: 1549205
  7. Abstinent chronic crack-cocaine and crackcocaine/alcohol abusers evidence normal hippocampal volumes on MRI despite persistent cognitive impairments.
    Addict Biol. 1998 Jul;3(3):261-70 PMID: 26734920
  8. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.
    Neurology. 1989 Sep;39(9):1159-65 PMID: 2771064
  9. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    Neurology. 1984 Jul;34(7):939-44 PMID: 6610841
  10. A new clinical scale for the staging of dementia.
    Br J Psychiatry. 1982 Jun;140:566-72 PMID: 7104545
  11. Random-effects models for longitudinal data.
    Biometrics. 1982 Dec;38(4):963-74 PMID: 7168798
  12. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.
    Neurology. 1994 Apr;44(4):609-14 PMID: 8164812
  13. The Clinical Dementia Rating (CDR): current version and scoring rules.
    Neurology. 1993 Nov;43(11):2412-4 PMID: 8232972
  14. Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation.
    Psychiatr Q. 1993 Winter;64(4):371-87 PMID: 8234547
  15. Staging of Alzheimer-related cortical destruction.
    Eur Neurol. 1993;33(6):403-8 PMID: 8307060
  16. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia.
    J Am Geriatr Soc. 1993 Jan;41(1):31-7 PMID: 8418119
  17. Hippocampal MR imaging morphometry by means of general pattern matching.
    Radiology. 1996 Jun;199(3):787-91 PMID: 8638006
  18. Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
    Age Ageing. 1996 May;25(3):209-13 PMID: 8670554
  19. Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas.
    Radiology. 1997 Feb;202(2):504-10 PMID: 9015081
  20. The effects of additional pathology on the cognitive deficit in Alzheimer disease.
    J Neuropathol Exp Neurol. 1997 Feb;56(2):165-70 PMID: 9034370
  21. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
    JAMA. 1997 Mar 12;277(10):813-7 PMID: 9052711
  22. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.
    Neurology. 1997 Sep;49(3):786-94 PMID: 9305341
  23. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.
    J Am Geriatr Soc. 1998 Apr;46(4):444-52 PMID: 9560066
  24. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects.
    Neurobiol Aging. 1998 Jan-Feb;19(1):23-31 PMID: 9562499
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
0028-3878
Published
2002-09-24
Pages
867-73
Language
English
Region
United States
NLM ID
0401060
PMCID
PMC1820873
Subset
IM
Grants
NIA NIH HHS · R01 AG010220 · United States
NIA NIH HHS · AG10129 · United States
NIA NIH HHS · R01 AG010897 · United States
NIA NIH HHS · P01 AG012435 · United States
NIA NIH HHS · AG10220 · United States
NIA NIH HHS · AG12435 · United States
NIA NIH HHS · P30 AG010129 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com